research Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
This study observed that both ritlecitinib and brepocitinib improved scalp biomarkers in patients with alopecia areata, with associations to hair regrowth seen in this phase 2a trial.




